EL7.AI
StocksHigh ImpactUpdated•Originally published 2 March 2026•Updated 2 March 2026•
1 min read

Allurion Appeals NYSE Delisting Notice, Presents Compliance Plan

Key Facts

1NYSE Regulation has determined to commence proceedings to delist the common stock and warrants of Allurion Technologies, Inc. (ALUR).
2Trading in the affected securities will continue on the NYSE until the delisting process is finalized.

Allurion Technologies (ALUR) has officially announced its intention to appeal the NYSE Regulation's decision to commence delisting proceedings for its common stock and warrants. The company clarified that the delisting notice stems from non-compliance with Section 802.01B, specifically regarding stockholders' equity falling below the $50 million threshold. In response, Allurion has developed a strategic plan aimed at regaining compliance with the exchange's listing standards. Trading of the company's securities will continue on the NYSE on a temporary basis pending the outcome of the appeal process. This proactive stance marks a shift as the company seeks to mitigate the negative impact on liquidity and institutional investor confidence. Market participants are now focusing on the feasibility of Allurion’s recovery plan and its potential to stabilize the stock price in the near term.